Galindo Alejandro
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Galindo Alejandro. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| MNKD | EVP Endocrine Business Unit | Sale | 15 | $3.84 | $58 | Aug 22, 2022 |
| MNKD | EVP Endocrine Business Unit | Award / Grant | 5,000 | $2.93 | $14,650 | Jul 31, 2022 |
| MNKD | EVP Endocrine Business Unit | Purchase | 5,000 | $2.93 | $14,650 | Jul 31, 2022 |
| MNKD | EVP Endocrine Business Unit | Tax Withholding | 4,789 | $3.19 | $15,277 | May 18, 2022 |
| MNKD | EVP Endocrine Business Unit | I | 4,789 | $3.19 | $15,277 | May 18, 2022 |
| MNKD | EVP Endocrine Business Unit | Award / Grant | 90,000 | — | — | May 10, 2022 |
| MNKD | EVP Endocrine Business Unit | Award / Grant | 36,900 | $2.71 | $99,999 | Feb 28, 2022 |
| MNKD | Chief Commercial Officer | Purchase | 36,900 | $2.71 | $99,999 | Feb 28, 2022 |
| MNKD | EVP Endocrine Business Unit | Award / Grant | 1,804 | $3.17 | $5,719 | Jan 31, 2022 |
| MNKD | Chief Commercial Officer | Purchase | 1,804 | $3.17 | $5,719 | Jan 31, 2022 |
| MNKD | Chief Commercial Officer | Purchase | 2,334 | $3.17 | $7,399 | Jan 31, 2022 |
| MNKD | Chief Commercial Officer | Tax Withholding | 9,616 | $4.91 | $47,215 | Aug 27, 2021 |
| MNKD | Chief Commercial Officer | Purchase | 5,000 | $2.99 | $14,950 | Jul 30, 2021 |
| MNKD | Chief Commercial Officer | Award / Grant | 79,000 | — | — | May 18, 2021 |
| MNKD | Chief Commercial Officer | Purchase | 34,602 | $2.89 | $100,000 | Dec 8, 2020 |
| MNKD | Chief Commercial Officer | Award / Grant | 164,000 | — | — | Aug 27, 2020 |
| MNKD | Chief Commercial Officer | Purchase | 34,602 | $2.89 | $100,000 | Nov 14, 2018 |